The significant down-regulation of cyclin B, cyclin D1, E2F1, survivin, and c-MYC in human RCC cells mediated by ART may be sufficient to arrest cell cycle progression and to suppress cancer stemness [53–59]. The gene discussed is MYC; the disease is renal cell carcinoma.